NOVACYT REVENUES HALF YEAR 2017 Consolidated sales growth +53% CER Group continues positive outlook for 2017

Novacyt revenues half year 2017 ENGLISH

Paris, France and Cambridge, UK – 20th July 2017 – Novacyt (ALTERNEXT: ALNOV), an international specialist in clinical diagnostics, today announces its unaudited revenues for the six months ended 30 June 2017 (the “Period”).